Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients
Articolo
Data di Pubblicazione:
2019
Abstract:
External beam radiotherapy (EBRT) is an effective treatment option for low- and favorable intermediate-risk prostate cancer (PCa) and it is usually delivered in conventional fractionation or with moderate hypofractionation (hRT), with comparable results. In the last years, a new treatment approach with stereotactic body radiotherapy (SBRT) has shown promising results. The aim of the present study was to directly compare the toxicity and outcome between hRT and SBRT in low and favorable intermediate PCa patients.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Favorable intermediate risk; Hypofractionated radiotherapy; Low risk; Prostate cancer; SBRT; Stereotactic body radiotherapy; Aged; Aged, 80 and over; Clinical Trials, Phase II as Topic; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Radiation Dose Hypofractionation; Radiosurgery
Elenco autori:
Nicosia, L.; Mazzola, R.; Rigo, M.; Figlia, V.; Giaj-Levra, N.; Napoli, G.; Ricchetti, F.; Corradini, S.; Ruggieri, R.; Alongi, F.
Link alla scheda completa:
Pubblicato in: